Humulin ® (human insulin)

This information is intended for UK registered healthcare professionals only as a scientific exchange in response to your search for information. Please refer to the link for full prescribing information: Humulin Summary of Product Characteristics (SmPC)

Humulin® S, Humulin® I, Humulin® M3 100 Units/ml (insulin human): Overdose

Insulin has no specific overdose definitions, because serum glucose concentrations are a result of complex interactions between insulin levels, glucose availability and other metabolic processes

Insulin has no specific overdose definitions, because serum glucose concentrations are a result of complex interactions between insulin levels, glucose availability and other metabolic processes. Hypoglycaemia may occur as a result of an excess of insulin relative to food intake and energy expenditure.

Hypoglycaemia may be associated with listlessness, confusion, palpitations, headache, sweating and vomiting.

Mild hypoglycaemic episodes will respond to oral administration of glucose or sugar products.

Correction of moderately severe hypoglycaemia can be accomplished by intramuscular or subcutaneous administration of glucagon, followed by oral carbohydrate when the patient recovers sufficiently. Patients who fail to respond to glucagon must be given glucose solution intravenously.

If the patient is comatose, glucagon should be administered intramuscularly or subcutaneously. However, glucose solution must be given intravenously, if glucagon is not available or if the patient fails to respond to glucagon. The patient should be given a meal as soon as consciousness is recovered.

Sustained carbohydrate intake and observation may be necessary because hypoglycaemia may occur after apparent clinical recovery.

Reference

Humulin S (soluble insulin) 100 cartridge Summary of Product Characteristics

Humulin S 100 vial Summary of Product Characteristics Characteristics

Humulin I (isophane insulin) 100 cartridge Summary of Product Characteristics

Humulin I 100 SPC KwikPen Summary of Product Characteristics

Humulin I 100 SPC vial Summary of Product Characteristics

Humulin M3 (30% soluble/70% isophane insulin) 100 cartridge Summary of Product Characteristics

Humulin M3 100 KwikPen Summary of Product Characteristics

Humulin M3 100 vial Summary of Product Characteristics

Date of Last Review: May 30, 2019

Contact Lilly

Call or Email us

If you want to ask a Medical Information question or you want to report an adverse event or product complaint you can call us or email us at ukmedinfo@lilly.com

Available Mon - Fri, 8am - 4pm, excluding Bank Holidays

Or you can

Ask us a question Chat with Us If you have a question, you can chat online with a Lilly Medical Information professional.

Submit a question